interventionelle, medikamentöse Studien
Titel
A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination with Other Anti-Tumor Agents as a Maintenance Treatment in Participants with Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress with First Line Platinum-Containing Chemotherapy
Indikation
Urothelkarzinom
Art der Studie
Therapiestudie, interventionell, Phase 2
Therapielinie
Zweitlinientherapie
Hauptprüfer am Zentrum (PI)
Prof. Dr. med. G. Gakis
Ansprechpartner
K. Biermann
Telefon: 0345/ 557 5810
Mail: karoline.biermann@uk-halle.de